Related Experiment Video
Updated: Nov 1, 2025

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
In-stent restenosis and stent compression following stenting for chronic iliofemoral venous obstruction
Arjun Jayaraj1, Robert Fuller1, Seshadri Raju1
1The RANE Center for Venous & Lymphatic Diseases, St. Dominic Hospital, Jackson, Miss.
Insights
In-stent restenosis (ISR) and stent compression (SC) are common after chronic iliofemoral venous stenting but not always progressive. Reintervention is indicated by symptoms, not just measurements, with good outcomes expected.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Cardiovascular Research
Background:
- In-stent restenosis (ISR) and stent compression (SC) are frequent complications following stenting for chronic iliofemoral venous obstruction.
- These complications are primary drivers for reintervention, yet their detailed characteristics and outcomes post-reintervention remain underexplored.
Purpose of the Study:
- To investigate the characteristics of ISR and SC after iliofemoral venous stenting.
- To analyze risk factors associated with the development of ISR and SC.
- To evaluate clinical outcomes and stent patency following reintervention for ISR and SC.
Main Methods:
- Retrospective analysis of 578 limbs/patients undergoing unilateral iliofemoral venous stenting (2014-2018).
- ISR and SC prevalence, onset, and progression assessed using duplex ultrasound and intravascular ultrasound.
- Risk factor analysis and reintervention outcomes, including patency rates and clinical improvement, were evaluated.
Main Results:
- ISR prevalence reached 74% by 3 months, while SC was noted in 80% on day 1, with both stabilizing thereafter.
- Significant risk factors for ISR included stent inflow luminal area and shear rate; asymmetric stent sizing was a risk factor for SC.
- 16.4% of limbs required reintervention, with significant improvements in swelling and pain scores post-reintervention. 60-month patency rates were high (70-98%).
Conclusions:
- ISR and SC are common but not relentlessly progressive after iliofemoral venous stenting.
- Reintervention decisions should prioritize symptomatic improvement and quality of life over arbitrary ISR/SC thresholds.
- Reintervention yields favorable clinical outcomes and long-term stent patency; further research into shear rate's role in ISR is warranted.
Objective:
In-stent restenosis (ISR) and stent compression (SC) are problems encountered after stenting for chronic iliofemoral venous obstruction that are responsible for a majority of reinterventions. However, characteristics of ISR and SC, in addition to outcomes after reintervention, have not been explored in detail and represent the focus of this study.
Methods:
A retrospective analysis of contemporaneously entered electronic medical record data on 578 limbs/patients with initial unilateral iliofemoral venous stents placed from 2014 to 2018 was performed. ISR was estimated from stent and flow channel diameters measured using duplex ultrasound. SC was estimated from rated stent diameter and actual stent diameter on duplex ultrasound. Characteristics evaluated included onset of ISR/SC after stent placement and progression over time. Analysis was performed to evaluate risk factors for the development of ISR and SC. Outcomes after reintervention for ISR/SC were also appraised.
Results:
A total of 578 limbs underwent stenting for stenotic lesions (nonthrombotic iliac vein lesion/post-thrombotic syndrome). ISR was noted in 27% of limbs on post-intervention day 1. The prevalence of ISR increased to 74% by 3 months and stabilized thereafter. SC was noted in 80% of limbs on day 1 and plateaued. Of the variables evaluated as potential risk factors for ISR, intravascular ultrasound determined stent inflow luminal area and shear rate were found to be significant. For SC, asymmetric stent sizing was a significant risk factor. Over a median follow-up of 24 months, 95 of 578 (16.4%) limbs underwent reintervention for ISR, SC, or a combination. The median time to reintervention was 11 months. There was no statistically significant difference in the degree of ISR/SC among patients who underwent reintervention vs those who did not (P > .05). However, there was a statistically significant difference in the grade of swelling (P = .006) and visual analog scale pain scores (P < .0001) between those who underwent reintervention and those who did not. Primary, primary assisted, and secondary patencies at 60 months were 70%, 98%, and 84% after reintervention for ISR and 70%, 99%, and 84% for SC, respectively.
Conclusions:
Although ISR and SC are both common after stenting for chronic iliofemoral venous obstruction, neither are relentlessly progressive. Indication for reintervention must be a recurrence of symptoms with impairment of quality of life and not the percentage of ISR or degree of SC. After reintervention good outcomes can be expected both in terms of clinical improvement and stent patency. Further study of the impact of shear rate on stent flow is required to help reduce the incidence of ISR.
More Related Videos
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
06:17Murine Model of Central Venous Stenosis using Aortocaval Fistula with an Outflow Stenosis
Published on: July 11, 2019
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis IV: Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management